Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.

Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF.

Clin Ther. 2009 Mar;31(3):632-43. doi: 10.1016/j.clinthera.2009.03.019.

PMID:
19393854
2.

The African American Heart Failure Trial: a clinical trial update.

Taylor AL.

Am J Cardiol. 2005 Oct 10;96(7B):44-8. Epub 2005 Aug 9. Review.

PMID:
16226935
4.

Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.

Elkayam U, Bitar F.

Am J Cardiol. 2005 Oct 10;96(7B):37i-43i. Epub 2005 Aug 9. Review.

PMID:
16226934
5.

Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.

Colvin-Adams M, Taylor AL.

Cleve Clin J Med. 2007 Mar;74(3):227-34. Review.

PMID:
17375804
6.

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.

Echols MR, Yancy CW.

Vasc Health Risk Manag. 2006;2(4):423-31. Review.

7.

Racial differences in heart failure therapeutics.

Ishizawar D, Yancy C.

Heart Fail Clin. 2010 Jan;6(1):65-74. doi: 10.1016/j.hfc.2009.08.006. Review.

PMID:
19945062
8.

Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.

Ferdinand KC, Elkayam U, Mancini D, Ofili E, PiƱa I, Anand I, Feldman AM, McNamara D, Leggett C.

Am J Cardiol. 2014 Jul 1;114(1):151-9. doi: 10.1016/j.amjcard.2014.04.018. Epub 2014 Apr 18. Review.

9.

Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.

Ferdinand KC.

Expert Rev Cardiovasc Ther. 2005 Nov;3(6):993-1001. Review.

PMID:
16292990
11.

African American heart failure trial: role of endothelial dysfunction and heart failure in African Americans.

Ferdinand KC.

Am J Cardiol. 2007 Mar 26;99(6B):3D-6D. Epub 2007 Jan 25. Review.

PMID:
17378993
12.

Racial differences in responses to drug treatment: implications for pharmacotherapy of heart failure.

Taylor JS, Ellis GR.

Am J Cardiovasc Drugs. 2002;2(6):389-99. Review.

PMID:
14727954
13.

Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.

Norgard NB, Stark JE.

Pharmacotherapy. 2008 Jul;28(7):920-31. doi: 10.1592/phco.28.7.920. Review.

PMID:
18576907
14.

How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.

Kahn J.

Yale J Health Policy Law Ethics. 2004 Winter;4(1):1-46. Review. No abstract available.

PMID:
15052858
15.

Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.

Franciosa JA.

Expert Opin Pharmacother. 2006 Dec;7(18):2521-31. Review.

PMID:
17150006
16.

The prevention of heart failure in minority communities and discrepancies in health care delivery systems.

Yancy CW.

Med Clin North Am. 2004 Sep;88(5):1347-68, xii-xiii. Review.

PMID:
15331320
17.

Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.

Klein L, O'Connor CM, Gattis WA, Zampino M, de Luca L, Vitarelli A, Fedele F, Gheorghiade M.

Am J Cardiol. 2003 May 8;91(9A):18F-40F. Review. Erratum in: Am J Cardiol. 2003 Dec 1;92(11):1378.

PMID:
12729848
18.

Racial response to angiotensin-converting enzyme therapy in systolic heart failure.

Dries DJ, Yancy CW, Strong MA, Drazner MH.

Congest Heart Fail. 2004 Jan-Feb;10(1):30-3. Review.

19.

Emerging role of pharmacogenomics in heart failure.

McNamara DM.

Curr Opin Cardiol. 2008 May;23(3):261-8. doi: 10.1097/HCO.0b013e3282fcd662. Review.

PMID:
18382216
20.

Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?

Ferdinand KC.

J Law Med Ethics. 2008 Fall;36(3):458-63. doi: 10.1111/j.1748-720X.2008.291.x. Review.

PMID:
18840236

Supplemental Content

Support Center